KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Cash from Operations: 2009-2024

Historic Cash from Operations for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $929.0 million.

  • Idexx Laboratories' Cash from Operations rose 82.82% to $402.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 18.68%. This contributed to the annual value of $929.0 million for FY2024, which is 2.48% up from last year.
  • Idexx Laboratories' Cash from Operations amounted to $929.0 million in FY2024, which was up 2.48% from $906.5 million recorded in FY2023.
  • In the past 5 years, Idexx Laboratories' Cash from Operations registered a high of $929.0 million during FY2024, and its lowest value of $543.0 million during FY2022.
  • Moreover, its 3-year median value for Cash from Operations was $906.5 million (2023), whereas its average is $792.8 million.
  • In the last 5 years, Idexx Laboratories' Cash from Operations fell by 28.13% in 2022 and then skyrocketed by 66.95% in 2023.
  • Over the past 5 years, Idexx Laboratories' Cash from Operations (Yearly) stood at $648.1 million in 2020, then rose by 16.59% to $755.5 million in 2021, then decreased by 28.13% to $543.0 million in 2022, then soared by 66.95% to $906.5 million in 2023, then increased by 2.48% to $929.0 million in 2024.